Boers M - Search Results

1

Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.

Direskeneli H, Aydin SZ, Kermani TA, Matteson EL, Boers M, Herlyn K, Luqmani RA, Neogi T, Seo P, Suppiah R, Tomasson G, Merkel PA. Direskeneli H, et al. Among authors: boers m. J Rheumatol. 2011 Jul;38(7):1471-9. doi: 10.3899/jrheum.110275. J Rheumatol. 2011. PMID: 21724719 Free PMC article.

2

OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction.

Tugwell P, Boers M. Tugwell P, et al. Among authors: boers m. J Rheumatol. 1993 Mar;20(3):528-30. J Rheumatol. 1993. PMID: 8478864 Review. No abstract available.

3

A method for achieving consensus on rheumatoid arthritis outcome measures: the OMERACT conference process.

Fried BJ, Boers M, Baker PR. Fried BJ, et al. Among authors: boers m. J Rheumatol. 1993 Mar;20(3):548-51. J Rheumatol. 1993. PMID: 8478870 Review.

4

The validity of pooled outcome measures (indices) in rheumatoid arthritis clinical trials.

Boers M, Tugwell P. Boers M, et al. J Rheumatol. 1993 Mar;20(3):568-74. J Rheumatol. 1993. PMID: 8478876

5

Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III.

Bellamy N, Kirwan J, Boers M, Brooks P, Strand V, Tugwell P, Altman R, Brandt K, Dougados M, Lequesne M. Bellamy N, et al. Among authors: boers m. J Rheumatol. 1997 Apr;24(4):799-802. J Rheumatol. 1997. PMID: 9101522 Review.

6

Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working Party. Outcome Measures in Rheumatology.

Gazarian M, Tugwell P, Boers M, Bombardier C, Brooks P, Day R, Strand V, Wells G. Gazarian M, et al. Among authors: boers m. J Rheumatol. 1999 Jan;26(1):207-9. J Rheumatol. 1999. PMID: 9918265

7

MCID/Low Disease Activity State Workshop: summary, recommendations, and research agenda.

Wells G, Anderson J, Boers M, Felson D, Heiberg T, Hewlett S, Johnson K, Kirwan J, Lassere M, Robinson V, Shea B, Simon L, Strand V, van Riel P, Tugwell P. Wells G, et al. Among authors: boers m. J Rheumatol. 2003 May;30(5):1115-8. J Rheumatol. 2003. PMID: 12734920 Review.

8

Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7.

Merkel PA, Seo P, Aries P, Neogi T, Villa-Forte A, Boers M, Cuthbertson D, Felson DT, Hellmich B, Hoffman GS, Jayne DR, Kallenberg CG, Krischer J, Mahr A, Matteson EL, Specks U, Luqmani R, Stone J; Vasculitis Clinical Research Consortium; OMERACT 7 Special Interest Group. Merkel PA, et al. Among authors: boers m. J Rheumatol. 2005 Dec;32(12):2488-95. J Rheumatol. 2005. PMID: 16331794 Review.

9

Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials.

Maksymowych WP, Landewe R, Boers M, Garnero P, Geusens P, El-Gabalawy H, Heinegard D, Kraus VB, Lohmander S, Matyas J, Saxne T, van der Heijde D. Maksymowych WP, et al. Among authors: boers m. J Rheumatol. 2007 Mar;34(3):634-40. J Rheumatol. 2007. PMID: 17343311

10

Assessing single joints in arthritis clinical trials.

Giles JT, Mease P, Boers M, Bresnihan B, Conaghan PG, Heald A, Maksymowych WP, Maillefert JF, Simon L, Tsuji W, Wakefield R, Woodworth T, Schumacher HR, Bingham CO 3rd. Giles JT, et al. Among authors: boers m. J Rheumatol. 2007 Mar;34(3):641-7. J Rheumatol. 2007. PMID: 17343312

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

620 results

Search Page